This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Achillion Pharmaceuticals, Inc.
Drug Names(s): ACH-2684.Na, ACH-0142684.Na, Neceprevir sodium
Description: ACH-2684 is a highly potent, pan-genotypic inhibitor of HCV NS3 protease with pico-molar potency. Achillion has demonstrated in vitro that ACH-2684 can be used in combination with other HCV inhibitors, and that it is synergistic with NS5B nucleoside polymerase inhibitors.
Additional information available to subscribers only: